Symbol | Exchange | Currency |
|---|
Robert W. Baird analyst Eric Coldwell maintained a Buy rating on AdaptHealth (NASDAQ:AHCO) on Tuesday, setting a price target of $34, which is approximately 53.08% above the...
Deutsche Bank (DE:DBKGn) analyst Pito Chickering reiterated a Buy rating on AdaptHealth (NASDAQ:AHCO) on Monday, setting a price target of $40, which is approximately 70.50%...
Jefferies (NYSE:JEF) analyst Brian Tanquilut maintained a Buy rating on AdaptHealth (NASDAQ:AHCO) on Wednesday, setting a price target of $48, which is approximately 74.80% above...
Investing in special purpose acquisition companies (SPACs), does not feel as glamorous lately. 2020 will possibly be remembered as the year when investors’ risk appetite for...
The market is enjoying the best of both worlds right now, as stocks have cooled off from the hectic pace earlier this month but are still managing new highs and strong weekly...
SPECIAL ALERT: Remember, the January episode of the Zacks Ultimate Strategy Session is now available for viewing! Don’t miss your chance to hear: ▪ Sheraz Mian and Dr....
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Neutral | Strong Sell | Neutral |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Sell | Sell |
| Summary | Strong Buy | Strong Buy | Buy | Strong Sell | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,738.60 | 2,765.00 | 2,706.70 | +100.6 | +3.81% | 2.69M | NASDAQ | |||
| 372.49 | 377.54 | 367.00 | +4.68 | +1.27% | 11.53M | NASDAQ | |||
| 68.66 | 68.85 | 67.01 | +1.17 | +1.73% | 3.99M | NYSE | |||
| 43.43 | 43.45 | 42.26 | +1.33 | +3.16% | 24.76M | NYSE | |||
| 194.63 | 196.40 | 189.76 | +8.56 | +4.60% | 21.51M | NYSE | |||
| 27.54 | 27.66 | 26.56 | +1.55 | +5.96% | 6.13M | NASDAQ | |||
| 436.42 | 444.66 | 432.87 | -31.08 | -6.65% | 1.05M | NYSE | |||
| 91.89 | 92.77 | 85.27 | +12.36 | +15.54% | 15.32M | NASDAQ | |||
| 53.36 | 53.92 | 52.94 | +0.18 | +0.34% | 14.51M | NASDAQ | |||
| 38.73 | 39.33 | 36.08 | +0.72 | +1.89% | 45.47M | NYSE | |||
| 75.70 | 75.90 | 74.39 | +1.48 | +1.99% | 7.26M | NASDAQ | |||
| 301.01 | 302.39 | 296.98 | +0.53 | +0.18% | 2.60M | NASDAQ | |||
| 16.01 | 16.18 | 14.02 | +3.28 | +25.77% | 81.72M | NASDAQ | |||
| 41.49 | 41.87 | 39.80 | +2.13 | +5.41% | 41.49M | NYSE | |||
| 6.205 | 6.24 | 6.11 | +0.055 | +0.89% | 5.30M | NYSE |
Adapthealth Corp. is a provider of home healthcare equipment, medical supplies to the home and related services in the United States. The Company is focused on primarily providing sleep therapy equipment, supplies and related services to individuals suffering from obstructive sleep apnea (OSA), home medical equipment (HME) to patients discharged from acute care and other facilities. The Company offers oxygen and related chronic therapy services in the home, and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy and nutritional supply needs. The company is also partners’ with diversified network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. The Company services beneficiaries of Medicare, Medicaid and commercial insurance payors and services over approximately 1.6 million patients annually.